Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 229.98 USD 0.04% Market Closed
Market Cap: 406.5B USD

Wall Street
Price Targets

ABBV Price Targets Summary
Abbvie Inc

Wall Street analysts forecast ABBV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABBV is 249.74 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

Lowest
Price Target
189.52 USD
18% Downside
Average
Price Target
249.74 USD
9% Upside
Highest
Price Target
303.45 USD
32% Upside
Abbvie Inc Competitors:
Price Targets
MDGL
Madrigal Pharmaceuticals Inc
2% Upside
AMRN
Amarin Corporation PLC
13% Downside
ARMP
Armata Pharmaceuticals Inc
40% Upside
CHRS
Coherus BioSciences Inc
335% Upside
DTIL
Precision BioSciences Inc
684% Upside
300142
Walvax Biotechnology Co Ltd
37% Downside
2256
Abbisko Cayman Ltd
79% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
90% Upside

Revenue
Forecast

Revenue Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

9%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

11%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Abbvie Inc

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

2%
Past Growth
65%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABBV's stock price target?
Price Target
249.74 USD

According to Wall Street analysts, the average 1-year price target for ABBV is 249.74 USD with a low forecast of 189.52 USD and a high forecast of 303.45 USD.

What is Abbvie Inc's Revenue forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for Abbvie Inc's revenue is 9%. The projected CAGR for the next 4 years is 9%.

What is Abbvie Inc's Operating Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Abbvie Inc's operating income is 11%. The projected CAGR for the next 4 years is 25%.

What is Abbvie Inc's Net Income forecast?
Projected CAGR
65%

For the last 13 years the compound annual growth rate for Abbvie Inc's net income is 2%. The projected CAGR for the next 4 years is 65%.

Back to Top